$0.152
0.01[7.04%]
At close: Apr 19
$0.152
0[0.00%]
After Hours: 8:58AM EDT
Cue Health
(NASDAQ:HLTH)Cue Health Stock (NASDAQ:HLTH), Analyst Ratings, Price Targets, Predictions
Cue Health Inc has a consensus price target of $3.88, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from BTIG, Goldman Sachs, and Goldman Sachs on March 14, 2024, November 10, 2023, and June 5, 2023. With an average price target of $0.42 between BTIG, Goldman Sachs, and Goldman Sachs, there's an implied 174.12% upside for Cue Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
BTIG
Goldman Sachs
Cowen & Co.
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cue Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2024 | HLTH | Buy Now | Cue Health | $0.15 | — | BTIG | Mark Massaro | — | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2023 | HLTH | Buy Now | Cue Health | $0.15 | 228.95% | Goldman Sachs | Matthew Sykes | $0.75 → $0.5 | Maintains | Neutral | Get Alert |
| 06/05/2023 | HLTH | Buy Now | Cue Health | $0.15 | 393.42% | Goldman Sachs | Matthew Sykes | $2.75 → $0.75 | Maintains | Neutral | Get Alert |
| 06/02/2023 | HLTH | Buy Now | Cue Health | $0.15 | 393.42% | Goldman Sachs | Matthew Sykes | $2.75 → $0.75 | Downgrade | Buy → Neutral | Get Alert |
| 05/15/2023 | HLTH | Buy Now | Cue Health | $0.15 | 1873.68% | BTIG | Mark Massaro | $5 → $3 | Maintains | Buy | Get Alert |
| 05/01/2023 | HLTH | Buy Now | Cue Health | $0.15 | 1873.68% | Goldman Sachs | Matthew Sykes | $3.5 → $3 | Maintains | Buy | Get Alert |
| 03/16/2023 | HLTH | Buy Now | Cue Health | $0.15 | 3189.47% | BTIG | Mark Massaro | → $5 | Maintains | Buy | Get Alert |
| 11/14/2022 | HLTH | Buy Now | Cue Health | $0.15 | 4505.26% | Cowen & Co. | Charles Rhyee | $9 → $7 | Maintains | Outperform | Get Alert |
| 11/09/2022 | HLTH | Buy Now | Cue Health | $0.15 | 4505.26% | BTIG | Mark Massaro | → $7 | Maintains | Buy | Get Alert |
| 10/21/2022 | HLTH | Buy Now | Cue Health | $0.15 | 3847.37% | Goldman Sachs | Matthew Sykes | $7 → $6 | Maintains | Buy | Get Alert |
| 08/12/2022 | HLTH | Buy Now | Cue Health | $0.15 | 5821.05% | BTIG | Mark Massaro | $11 → $9 | Maintains | Buy | Get Alert |
| 08/11/2022 | HLTH | Buy Now | Cue Health | $0.15 | 5163.16% | Morgan Stanley | Tejas Savant | $10 → $8 | Maintains | Equal-Weight | Get Alert |
| 05/12/2022 | HLTH | Buy Now | Cue Health | $0.15 | 6478.95% | Morgan Stanley | Tejas Savant | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | HLTH | Buy Now | Cue Health | $0.15 | 7136.84% | Morgan Stanley | Tejas Savant | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 10/19/2021 | HLTH | Buy Now | Cue Health | $0.15 | 7794.74% | Morgan Stanley | Tejas Savant | — | Initiates | → Equal-Weight | Get Alert |
| 10/19/2021 | HLTH | Buy Now | Cue Health | $0.15 | 12400% | Goldman Sachs | Matthew Sykes | — | Initiates | → Buy | Get Alert |
| 10/19/2021 | HLTH | Buy Now | Cue Health | $0.15 | 9110.53% | Cowen & Co. | Charles Rhyee | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Cue Health (HLTH)?
The latest price target for Cue Health (NASDAQ: HLTH) was reported by BTIG on March 14, 2024. The analyst firm set a price target for $0.00 expecting HLTH to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cue Health (HLTH)?
The latest analyst rating for Cue Health (NASDAQ: HLTH) was provided by BTIG, and Cue Health downgraded their neutral rating.
When was the last upgrade for Cue Health (HLTH)?
There is no last upgrade for Cue Health.
When was the last downgrade for Cue Health (HLTH)?
The last downgrade for Cue Health Inc happened on March 14, 2024 when BTIG changed their price target from N/A to N/A for Cue Health Inc.
When is the next analyst rating going to be posted or updated for Cue Health (HLTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cue Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cue Health was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.
Is the Analyst Rating Cue Health (HLTH) correct?
While ratings are subjective and will change, the latest Cue Health (HLTH) rating was a downgraded with a price target of $0.00 to $0.00. The current price Cue Health (HLTH) is trading at is $0.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.